Discover the origins of MITOS Medical Technologies, our milestones, and how two decades of rigorous research have propelled us to the forefront of medical innovation.
MITOS Medical Technologies is at the forefront of innovation in medical diagnostics, committed to revolutionizing breast cancer screening and diagnosis. Our flagship product, SAFE (Scan and Find Early), embodies our dedication to advanced healthcare solutions that emphasize patient well-being and proactive intervention.
SAFE (Scan and Find Early) is a state-of-the-art microwave imaging device designed for breast cancer screening and diagnosis. It harnesses harmless electromagnetic waves in a non-invasive manner, providing crucial breast health information without exposing patients to ionizing radiation. Moreover, the device's design significantly reduces the discomfort associated with breast compression, making the scanning process comfortable and pain-free for patients.
To affirm its efficacy, SAFE has been meticulously examined in over a thousand patients, revealing remarkable accuracy, sensitivity, and specificity rates of 82%, 81%, and 83%, respectively. This extensive evaluation not only demonstrates SAFE's consistent performance across various breast sizes but also highlights its alignment with clinical reports. Such promising outcomes underscore SAFE's potential to significantly improve early detection rates, making it a valuable addition to current diagnostic tools like magnetic resonance imaging (MRI), ultrasound, and mammography.
At MITOS, we're dedicated to empowering individuals with innovative solutions for proactive breast health management. Our pioneering project, SAFE, is in the clinical trial stage and is being developed to potentially revolutionize the way breast health monitoring is approached, starting from the age of 18. SAFE's use of safe electromagnetic waves offers a future where frequent, non-invasive screenings can become a reality, minimizing the risks linked with traditional X-ray exposure. Our goal is to make early detection more accessible and effective, paving the way for timely intervention and enhancing treatment outcomes. Through SAFE, we envision a world where every individual has the power to monitor their breast health confidently and efficiently.
Our commitment to innovation goes well beyond our flagship product, SAFE. At MITOS, we are relentless in our pursuit to develop accessible, safe healthcare technologies that meet crucial medical needs. Our efforts include vigorous research and development aimed not only at enhancing SAFE's functionalities but also at broadening its applications in the critical areas of breast cancer screening and diagnosis. Our vision is for SAFE to become an essential tool in the global fight against breast cancer, significantly improving patient outcomes. Through continuous innovation, we aspire to lead the way in creating healthcare solutions that truly make a difference in people's lives.
Embark on a transformative journey with us to revolutionize breast cancer detection and screening. Together, we have the power to make a significant difference in the lives of millions by offering tools for early detection and intervention that are not only safe and effective but also accessible to all. We invite healthcare professionals, researchers, investors, and advocates to contact MITOS Medical Technologies today. Discover more about our groundbreaking solutions and find out how you can contribute to this vital cause. Let’s unite in our mission to save lives and change the future of breast health.